Skip to main content
Home
language-selector-globe Slovenia | en
Choose Location
language-selector-globe Slovenia |
EnglishSlovenian
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | es
Brazil | pt
Canada | en
Canada | fr
Central America | es
Colombia | es
Latin America | es
Mexico | es
United States | en
Venezuela | es
Australia | en
Bangladesh | en
Hong Kong S.A.R. | zh
India | en
Indonesia | en
Japan | ja
Korea | ko
Mainland China | zh
Malaysia | en
Pakistan | en
Philippines | en
Singapore | en
Taiwan | zh
Austria | de
Belgium | fr
Belgium | nl
Bulgaria | bg
Czech Republic | cs
Czech Republic | en
Denmark | da
Estonia | et
Finland | fi
France | fr
Germany | de
Greece | el
Hungary | hu
Ireland | en
Israel | he
Italy | it
Latvia | lv
Lithuania | lt
Netherlands | nl
Norway | no
Poland | pl
Portugal | pt
Romania | ro
Russia | ru
Serbia | sr
Slovakia | sk
Slovenia | sl
Slovenia | en
Spain | es
Sweden | sv
Switzerland | de
Switzerland | fr
United Kingdom | en
Novartis | en
Sandoz | en
Egypt | en
South Africa | en
Turkey | tr
language-selector-globe si
Choose Location
language-selector-globeSlovenia
EnglishSlovenian
Americas Asia Pacific Europe International Middle East & Africa
Argentina | es
Australia | en
Austria | de
Bangladesh | en
Belgium | fr
Belgium | nl
Brazil | pt
Bulgaria | bg
Canada | en
Canada | fr
Central America | es
Colombia | es
Czech Republic | cs
Czech Republic | en
Denmark | da
Egypt | en
Estonia | et
Finland | fi
France | fr
Germany | de
Greece | el
Hong Kong S.A.R. | zh
Hungary | hu
India | en
Indonesia | en
Ireland | en
Israel | he
Italy | it
Japan | ja
Korea | ko
Latin America | es
Latvia | lv
Lithuania | lt
Mainland China | zh
Malaysia | en
Mexico | es
Netherlands | nl
Norway | no
Novartis | en
Pakistan | en
Philippines | en
Poland | pl
Portugal | pt
Romania | ro
Russia | ru
Sandoz | en
Serbia | sr
Singapore | en
Slovakia | sk
Slovenia | sl
Slovenia | en
South Africa | en
Spain | es
Sweden | sv
Switzerland | de
Switzerland | fr
Taiwan | zh
Turkey | tr
United Kingdom | en
United States | en
Venezuela | es
    • About 
      • Novartis in Slovenia 
      • Country Leadership Team 
      • Strategy 
      • Diversity, Equity and Inclusion 
      • People and culture 
      • Products 
      • Contacts 
      Novartis in Slovenia. Scientist in laboratory About
    • Patients and Caregivers 
      • Novartis Commitment to Patients and Caregivers 
      • Adverse Event Reporting 
      • Diseases 
      • Products 
      Older patient and younger caregiver Patients and Caregivers
    • Healthcare Professionals 
      • Healthcare professional country resource 
      • Products 
      • Pipeline 
      • Adverse Event Reporting 
      • Clinical studies 
      Elderly gentleman at a doctor's appointment Healthcare Professionals
    • ESG 
      • Ethics, risk and compliance 
      • Access 
      • Environmental Sustainability 
      • Global Health 
      • Ethical Behavior 
      • Reporting 
      Two people holding hands ESG
    • Media 
      • News Archive 
      • Media Contact 
      Man reading newspaper Media
    • Careers 
      • Careers at Novartis in Slovenia 
      • How We Work 
      • Wellbeing 
      • Diversity, Equity and Inclusion 
      • BioCamp 
      • Meet the teams 
      • Personal Growth 
      • Early Talent 
      • Awards and Recognition 
      Man and woman behind computer Careers
    • Development and production of innovative medicines 
    • BioCamp 2024 
    Scientist, Novartis in Slovenia Home
  1. Home
  2. Careers
  3. Career Search
  • Sort by Sort ascending
  • Job Title
  • Site
  • Location
  • Division
  • Business
  • Functional Area
  • Date Posted Sort ascending
Job Title Site Location Division Business Functional Area Date Posted Sort ascending
Allergy- Territory Account Specialist- Corpus Christi- Remote Field Sales (USA) USA US Innovative Medicines Sales 23 October 2024
Sr. Specialist (SAP Business Process Automation) Hyderabad (Office) India Operations CTS Technology Transformation 23 October 2024
Assoc. Director- Solutions Delivery (SAP Business Process Automation) Hyderabad (Office) India Operations CTS Technology Transformation 23 October 2024
Business Data Migration Lead INSURGENTES Mexico Operations CTS BD&L & Strategic Planning 23 October 2024
AS&T specialist (m/ž/d) Mengeš Slovenia Operations Innovative Medicines Quality 23 October 2024
AS&T specialist (m/ž/d) Mengeš Slovenia Operations Innovative Medicines Quality 23 October 2024
Neuroscience Territory Account Specialist – Boise, ID – Remote Field Sales (USA) USA US Innovative Medicines Sales 23 October 2024
Record to Report Sr. Specialist USA INSURGENTES Mexico Finance CTS Audit & Finance 23 October 2024
Site Quality Head, Indianapolis Isotopes Site Indianapolis USA Operations Innovative Medicines Quality 23 October 2024
Executive Assistant Taipei Taiwan International Innovative Medicines Facilities & Administration 23 October 2024
Specialist - Quality Operations Hyderabad (Office) India Operations Innovative Medicines Quality 23 October 2024
Associate Director, Business Transformation & Engagement Barcelona Gran Vía Spain Development Innovative Medicines Communications & Public Affairs 23 October 2024
(高级)医药代表 /(资深)产品专员 Anqing (Anhui Province) China International Innovative Medicines Sales 23 October 2024
(高级)医药代表 /(资深)产品专员 Shanghai (Shanghai) China International Innovative Medicines Sales 23 October 2024
Global Benchmarking Process Expert Hyderabad (Office) India People & Organization CTS Human Resources 23 October 2024
Cardiovascular Therapeutic Area Head Warsaw Poland International Innovative Medicines Commercial & General Management 23 October 2024
Business Planning Analysis Manager / Analyst INSURGENTES Mexico Biomedical Research CTS Audit & Finance 23 October 2024
(高级)医药代表 /(资深)产品专员 Anqing (Anhui Province) China International Innovative Medicines Sales 23 October 2024
(高级)医药代表 /(资深)产品专员 Shanghai (Shanghai) China International Innovative Medicines Sales 23 October 2024
Liaison en sciences médicales - Cancer du sein Field Non-Sales (Canada) Canada International Innovative Medicines Research & Development 23 October 2024
Associate or Manager, PHAD Japan Head Office (Japan) (Pharmaceuticals) Japan Development Innovative Medicines Research & Development 23 October 2024
(高级)医药代表 /(资深)产品专员 Anqing (Anhui Province) China International Innovative Medicines Sales 23 October 2024
(高级)医药代表 /(资深)产品专员 Shanghai (Shanghai) China International Innovative Medicines Sales 23 October 2024
(高级)医药代表 /(资深)产品专员 Anqing (Anhui Province) China International Innovative Medicines Sales 23 October 2024
(高级)医药代表 /(资深)产品专员 Shanghai (Shanghai) China International Innovative Medicines Sales 23 October 2024
(高级)医药代表 /(资深)产品专员 Anqing (Anhui Province) China International Innovative Medicines Sales 23 October 2024
(高级)医药代表 /(资深)产品专员 Shanghai (Shanghai) China International Innovative Medicines Sales 23 October 2024
(高级)医药代表 /(资深)产品专员 Anqing (Anhui Province) China International Innovative Medicines Sales 23 October 2024
(高级)医药代表 /(资深)产品专员 Shanghai (Shanghai) China International Innovative Medicines Sales 23 October 2024
(高级)医药代表 /(资深)产品专员 Anqing (Anhui Province) China International Innovative Medicines Sales 23 October 2024
(高级)医药代表 /(资深)产品专员 Shanghai (Shanghai) China International Innovative Medicines Sales 23 October 2024
(高级)医药代表 /(资深)产品专员 Jinhua (Zhejiang Province) China International Innovative Medicines Sales 23 October 2024
(高级)医药代表 /(资深)产品专员 Tianjin (Tianjin) China International Innovative Medicines Sales 23 October 2024
(高级)医药代表 /(资深)产品专员 Anqing (Anhui Province) China International Innovative Medicines Sales 23 October 2024
(高级)医药代表 /(资深)产品专员 Zhenjiang (Jiangsu Province) China International Innovative Medicines Sales 23 October 2024
(高级)医药代表 /(资深)产品专员 Shanghai (Shanghai) China International Innovative Medicines Sales 23 October 2024
MR Enshi (Hubei Province) China International Innovative Medicines Sales 22 October 2024
Pharmaziepraktikant (w/m/d) im Quality Management ab Mai 2025 Nuremberg (Non-Sales Force) (Novartis Pharma GmbH) Germany Operations Innovative Medicines Others 22 October 2024
MR Enshi (Hubei Province) China International Innovative Medicines Sales 22 October 2024
Recent Bachelor or Master Graduate Basel (City) Switzerland Biomedical Research Pharma Research Others 22 October 2024
Assistant(e) de Coordination Accès au Marché H/F Paris Headquarter (Novartis Pharma S.A.S.) France International Innovative Medicines Market Access 22 October 2024
Capability Building Manager Milano Italy International Innovative Medicines Sales 22 October 2024
MR Enshi (Hubei Province) China International Innovative Medicines Sales 22 October 2024
Vodja ekipe za mednarodno trgovino (m/ž/d) / International Trade Team Lead (m/f/d) Ljubljana Slovenia Operations Innovative Medicines Technical Operations 22 October 2024
Director DDIT GF P&O Solution Delivery and Business Partnering Prague Czech Republic Operations CTS Technology Transformation 22 October 2024
Engagement Services Expert (Japanese speaker) Selangor Malaysia People & Organization CTS Human Resources 22 October 2024
Senior Manager- Master Data Management Hyderabad (Office) India Operations Innovative Medicines Technical Operations 22 October 2024
Laboratory Operational Technology and Applications Engineer East Hanover USA Development Innovative Medicines Technical Operations 22 October 2024
Associate Director, Corporate Event Marketing East Hanover (New Jersey) USA Corporate Affairs CTS Communications & Public Affairs 22 October 2024
IT Devops Lead (Data Science Platform) Barcelona Gran Vía Spain Operations CTS Technology Transformation 22 October 2024

Pagination

  • ‹ Previous page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 42
  • › Next page

Novartis Slovenia

Navigate Novartis
  • Patients & Caregivers
  • Healthcare Professionals
  • ESG
  • Media
  • Career
Media
  • News Archive
Our Portfolio
  • Novartis Products
  • Novartis Pipeline
Other Novartis websites
  • Global site
Footer Bottom
© 2024 Novartis d.o.o.
  • Privacy Policy
  • Terms of Use
  • Cookie Settings
  • Site Map
  • Web Accessibility
Novartis Site Directory
This site is intended for a global audience